ERA PerMed is a new ERA-Net Cofund, supported by 32 partners from 23 countries and cofunded by the European Commission. To align national research strategies, promote excellence, reinforce the competitiveness of European players in PM, and enhance the European collaboration with non-EU countries, national funding organisations have agreed to launch Joint Transnational Calls for collaborative innovative research projects in Personalised Medicine (PM).

Coordinator:  Nacional Institute of Health Carlos III – Instituto de Salud Carlos III

The Joint Transnational Call 2022 is already open and published, for further information, please consult here. The Information Day for JTC2022 was held on 9th December at 13:00 CET, agenda, presentations and video recording are available here

An Open Consultation for the “European Partnership for Personalised Medicine – EP PerMed” has been launched. It will be closed on 21st December 2022. 

Please have a look to the videos of the video competition “The story behind our personalised medicine research project” of cofunded JTC2018 projects. Voting is open until 25th November 2022.